{"paper_id":"848f64ba-a519-4ed0-9c5d-6349819e478f","body_text":"Prognostic Assessment of Fertility Potential in Women with Endometriosis\nDOI:\nhttps://doi.org/10.12775/JEHS.2026.93.75604Keywords\nendometriosis, infertility, ovarian reserve, microRNA, oxidative stressAbstract\nAim. To identify and evaluate clinical, hormonal, biochemical, and molecular markers that can predict fertility potential and reproductive outcomes in women with endometriosis.\nMaterials and Methods. The study included 58 women aged 25–48 years with external genital endometriosis and 20 healthy fertile controls. Diagnosis was based on clinical assessment, ultrasound, and, when available, intraoperative findings. Clinical evaluation included reproductive history, infertility duration, and pain severity assessed by VAS. Hormonal analysis included AMH, FSH, LH, and estradiol levels. Oxidative stress markers (MDA, SOD, TAC), cytokines (IL-6, TNF-α, IL-10), apoptosis-related proteins (Bax, Bcl-2, caspase-3), and microRNA expression (miR-21, miR-200, miR-135a/b) were assessed using ELISA and qRT-PCR. Disease severity was classified using rASRM, Enzian, AAGL systems, and reproductive prognosis was evaluated using the Endometriosis Fertility Index (EFI). Statistical analysis included comparative tests, correlation analysis, logistic regression, and ROC analysis.\nResults. Infertility was observed in 79.3% of women with endometriosis, with a mean duration of 4.3 ± 1.7 years. AMH levels were significantly lower compared with controls (1.9 ± 0.7 vs 2.8 ± 0.9 ng/mL, p < 0.01), indicating reduced ovarian reserve. Increased oxidative stress was confirmed by elevated MDA and decreased antioxidant parameters (SOD, TAC). Pro-inflammatory cytokines (IL-6, TNF-α) were significantly elevated, while IL-10 levels were reduced. Molecular analysis showed increased miR-21 and miR-135a/b expression and decreased miR-200 levels, associated with disease severity and infertility. Moderate and severe endometriosis accounted for over 60% of cases. EFI scores indicated low reproductive prognosis in 19.0%, moderate in 43.1%, and favorable in 37.9% of patients. Logistic regression identified reduced AMH, elevated IL-6, increased MDA, and altered microRNA expression as key predictors of unfavorable reproductive outcomes. ROC analysis demonstrated good predictive performance of the integrated model.\nConclusion. Endometriosis-associated infertility is determined not only by anatomical disease extent but also by systemic inflammation, oxidative stress, reduced ovarian reserve, and dysregulated microRNA expression. Integration of clinical, hormonal, and molecular markers significantly improves prognostic assessment and supports personalized reproductive management in women with endometriosis.\nReferences\n1. Saunders PTK, Horne AW. Endometriosis: new insights and opportunities for relief of symptoms. Biol Reprod. 2025 Nov 14;113(5):1029-1043. doi: 10.1093/biolre/ioaf164. PMID: 40704733; PMCID: PMC12621312.\n2. Masferrer-Ferragutcasas, C., Delgado-Gil, R. & Colas, E. Rethinking endometriosis recurrence: from clinical challenge to biological opportunity. npj Womens Health 4, 4 (2026). https://doi.org/10.1038/s44294-026-00128-9\n3. Kalaitzopoulos DR, Kohl Schwartz AS. Fertility preservation in women with endometriosis: How, when, and for whom? J Int Med Res. 2026 Feb;54(2):3000605261422887. doi: 10.1177/03000605261422887. Epub 2026 Feb 20. PMID: 41719432; PMCID: PMC12924948.\n4. Shah H, Salleh N, Hamdan M, Giribabu N. Molecular mechanisms in endometriosis: linking JAK/STAT pathway, ferroptosis, and microbial dysbiosis. Mol Biol Rep. 2026 Feb 14;53(1):387. doi: 10.1007/s11033-025-11401-6. PMID: 41689677.\n5. Tcherniakovsky M, Carneiro MM, da Cunha JSL, Petta CA, Lino CAPC, de Castro CLA, Schor E, Nogueira J, de Oliveira MAP, Abrão MS, Poli OB, Quintairos RA, Pearce S, Abdalla HS, Podgaec S, Silva JCRE. Treatment of ovarian endometriosis: Number 1 - 2026. Rev Bras Ginecol Obstet. 2026 Feb 12;48:e-FPS1. doi: 10.61622/rbgo/2026FPS1. PMID: 41815928; PMCID: PMC12975110.\n6. Eichinger T, Oppelt P, Lastinger J, Palasz NA, Fickert HE, Enzelsberger SH. Current Endometriosis Classifications (rASRM, #Enzian, AAGL2021) and their Correlation with Operative Time. Geburtshilfe Frauenheilkd. 2025 Sep 25;86(2):201-207. doi: 10.1055/a-2697-6364. PMID: 41684532; PMCID: PMC12893800.\n7. Moïse A, Dzeitova M, de Landsheere L, Nisolle M, Brichant G. Endometriosis and Infertility: Gynecological Examination Practical Guide. J Clin Med. 2025 Mar 12;14(6):1904. doi: 10.3390/jcm14061904. PMID: 40142712; PMCID: PMC11943251.\n8. Ferrier C, Boujenah J, Poncelet C, Chabbert-Buffet N, Mathieu D'Argent E, Carbillon L, Grynberg M, Darai E, Bendifallah S. Use of the EFI score in endometriosis-associated infertility: A cost-effectiveness study. Eur J Obstet Gynecol Reprod Biol. 2020 Oct;253:296-303. doi: 10.1016/j.ejogrb.2020.08.031. Epub 2020 Aug 27. PMID: 32920265.\n9. Pickup B, Sharpe L, Todd J. Interpretation bias in endometriosis-related pain. Pain. 2023 Oct 1;164(10):2352-2357. doi: 10.1097/j.pain.0000000000002946. Epub 2023 Jun 15. PMID: 37326698.\n10. Bouic PJ. Endometriosis and infertility: the hidden link between endometritis, hormonal imbalances and immune dysfunctions preventing implantation! JBRA Assist Reprod. 2023 Jun 22;27(2):144-146. doi: 10.5935/1518-0557.20230015. PMID: 37348006; PMCID: PMC10279451.\n11. Amini L, Chekini R, Nateghi MR, Haghani H, Jamialahmadi T, Sathyapalan T, Sahebkar A. The Effect of Combined Vitamin C and Vitamin E Supplementation on Oxidative Stress Markers in Women with Endometriosis: A Randomized, Triple-Blind Placebo-Controlled Clinical Trial. Pain Res Manag. 2021 May 26;2021:5529741. doi: 10.1155/2021/5529741. PMID: 34122682; PMCID: PMC8172324.\n12. Cytokines. In: Encyclopedic Reference of Molecular Pharmacology. Springer, Berlin, Heidelberg. 2004 https://doi.org/10.1007/3-540-29832-0_463\n13. Flores‐Romero, H., Hohorst, L., John, M. et al. BCL‐2‐family protein tBID can act as a BAX‐like effector of apoptosis. EMBO J 41, EMBJ2021108690 (2022). https://doi.org/10.15252/embj.2021108690\n14. Varkonyi-Gasic E, Wu R, Wood M, Walton EF, Hellens RP. Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods. 2007 Oct 12;3:12. doi: 10.1186/1746-4811-3-12. PMID: 17931426; PMCID: PMC2225395.\n15. Keckstein J, Saridogan E, Ulrich U A, et al. The #Enzian classification: A comprehensive non-invasive and surgical description system for endometriosis. Acta Obstet Gynecol Scand. 2021;100:1165–1175. https://doi.org/10.1111/aogs.14099\n16. Abrao MS, Andres MP, Miller CE, Gingold JA, Rius M, Neto JS, Carmona F. AAGL 2021 Endometriosis Classification: An Anatomy-based Surgical Complexity Score. J Minim Invasive Gynecol. 2021 Nov;28(11):1941-1950.e1. doi: 10.1016/j.jmig.2021.09.709. Epub 2021 Sep 25. PMID: 34583009.\n17. Pavić I, Alfirević N, Vuletić S, editors. Bioethics and social ethics in the modern world: The environmental and social sustainability context(s). 1st ed. Cham: Palgrave Macmillan; 2025. 223 p. doi:10.1007/978-3-031-86418-6\n18. Leeuw, J.d., Lovric, M. (2025). Statistical Software: Overview. In: Lovric, M. (eds) International Encyclopedia of Statistical Science. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-69359-9_629\nDownloads\nPublished\nHow to Cite\nIssue\nSection\nLicense\nCopyright (c) 2026 D. Anufriev, V. Marichereda\nThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.\nThe periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0\nStats\nNumber of views and downloads: 92\nNumber of citations: 0","source_license":"CC0","license_restricted":false}